XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Class A
Common Class B
Common Stock
Common Class A
Common Stock
Common Class A
RSUs
Common Stock
Common Class A
RSAs
Common Stock
Common Class B
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020       103,394,000     10,229,000      
Beginning balance at Dec. 31, 2020 $ 1,061,865     $ 1     $ 1 $ 1,350,050 $ 6 $ (288,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       2,188,000            
Exercise of vested stock options 12,626             12,626    
Vesting of early exercised stock options (in shares)       48,000     43,000      
Vesting of early exercised stock options 405             405    
Vesting of restricted stock (in shares)         2,000,000 448,000        
Proceeds from sale of restricted shares (in shares)       224,000            
Proceeds from sale of restricted shares 10,655             10,655    
Shares issued under employee stock purchase program (in shares)       236,000            
Shares issued under employee stock purchase program 8,798             8,798    
Stock-based compensation 144,934             144,934    
Conversion of Class B to Class A Stock (in shares)       10,272,000     (10,272,000)      
Conversion of Class B common stock to Class A common stock 0     $ 1     $ (1)      
Net loss (222,697)                 (222,697)
Other comprehensive income (loss) (2,633)               (2,633)  
Ending balance (in shares) at Dec. 31, 2021       118,811,000     0      
Ending balance at Dec. 31, 2021 1,013,953     $ 2     $ 0 1,527,468 (2,627) (510,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)       1,778,000            
Exercise of vested stock options 5,688             5,688    
Vesting of restricted stock (in shares)         3,119,000 112,000        
Shares issued under employee stock purchase program (in shares)       516,000            
Shares issued under employee stock purchase program 4,665             4,665    
Stock-based compensation 128,285             128,285    
Net loss (190,774)                 (190,774)
Other comprehensive income (loss) $ (6,659)               (6,659)  
Ending balance (in shares) at Dec. 31, 2022 124,336,171 124,300,000   124,336,000     0      
Ending balance at Dec. 31, 2022 $ 955,158     $ 2     $ 0 1,666,106 (9,286) (701,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares) 291,000     291,000            
Exercise of vested stock options $ 2,169             2,169    
Vesting of restricted stock (in shares)         6,150,000          
Vesting of restricted stock units 1       $ 1          
Shares issued under bonus program (in shares)       1,193,000            
Shares issued under bonus program 16,599             16,599    
Shares issued under employee stock purchase program (in shares)       1,022,000            
Shares issued under employee stock purchase program 8,692             8,692    
Stock-based compensation 121,679             121,679    
Net loss (133,088)                 (133,088)
Other comprehensive income (loss) $ 8,278               8,278  
Ending balance (in shares) at Dec. 31, 2023 132,992,126 133,000,000 0 132,992,000     0      
Ending balance at Dec. 31, 2023 $ 979,488     $ 3     $ 0 $ 1,815,245 $ (1,008) $ (834,752)